Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Monique Spillman

Concepts (262)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Ovarian Neoplasms
17
2023
474
1.980
 Why?
Endometrial Neoplasms
5
2015
145
0.920
 Why?
Gynecology
5
2020
50
0.890
 Why?
Genital Neoplasms, Female
2
2020
41
0.830
 Why?
Gene Expression Regulation, Neoplastic
10
2019
868
0.790
 Why?
Cystadenocarcinoma, Serous
4
2021
74
0.770
 Why?
Ethics, Medical
1
2020
41
0.730
 Why?
Infection Control
1
2020
58
0.720
 Why?
Communication
1
2020
265
0.640
 Why?
Conflict of Interest
3
2016
24
0.640
 Why?
Uterus
1
2018
100
0.620
 Why?
Medical Oncology
3
2020
110
0.620
 Why?
Robotics
2
2014
45
0.600
 Why?
Receptors, Estrogen
5
2017
131
0.590
 Why?
Pneumonia, Viral
1
2020
184
0.580
 Why?
Peptides
3
2015
276
0.570
 Why?
Coronavirus Infections
1
2020
192
0.570
 Why?
Medroxyprogesterone Acetate
1
2015
6
0.560
 Why?
Fallopian Tube Neoplasms
2
2013
19
0.550
 Why?
Antineoplastic Agents, Hormonal
1
2015
49
0.540
 Why?
Glycoproteins
1
2015
132
0.520
 Why?
Gynecologic Surgical Procedures
2
2014
31
0.520
 Why?
Pandemics
1
2020
593
0.510
 Why?
Neoplastic Stem Cells
1
2015
104
0.510
 Why?
Antigens, CD
1
2015
242
0.490
 Why?
Adenocarcinoma
2
2015
428
0.490
 Why?
Salpingectomy
1
2013
6
0.460
 Why?
Peritoneal Neoplasms
2
2011
61
0.450
 Why?
Pelvic Neoplasms
1
2013
20
0.440
 Why?
General Surgery
1
2014
113
0.440
 Why?
Female
34
2023
28457
0.440
 Why?
MicroRNAs
4
2021
386
0.440
 Why?
Estrogens
2
2012
244
0.430
 Why?
Professional Corporations
1
2011
1
0.410
 Why?
Medicare Part B
1
2011
6
0.410
 Why?
Marketing of Health Services
1
2011
10
0.410
 Why?
Reimbursement Mechanisms
1
2011
25
0.410
 Why?
Clinical Trials as Topic
2
2007
490
0.410
 Why?
Social Responsibility
1
2011
28
0.410
 Why?
Receptors, Progesterone
4
2015
57
0.400
 Why?
Physicians
2
2016
244
0.400
 Why?
Trust
1
2011
64
0.390
 Why?
Cell Line, Tumor
11
2016
1551
0.390
 Why?
Carcinoma, Large Cell
1
2010
17
0.380
 Why?
Carcinoma, Neuroendocrine
1
2010
27
0.380
 Why?
Interprofessional Relations
1
2011
94
0.380
 Why?
Health Care Reform
1
2010
28
0.380
 Why?
Physician-Patient Relations
1
2011
134
0.370
 Why?
Humans
42
2023
54304
0.370
 Why?
Breast Neoplasms
4
2012
1248
0.340
 Why?
Uterine Neoplasms
2
2019
65
0.320
 Why?
Transplantation, Heterologous
2
2012
76
0.320
 Why?
Uterine Cervical Neoplasms
1
2010
276
0.310
 Why?
Physician's Role
2
2011
51
0.300
 Why?
MAP Kinase Kinase 4
1
2007
34
0.300
 Why?
Patient Dropouts
1
2007
58
0.290
 Why?
Advance Directives
1
2007
36
0.290
 Why?
Genes, Tumor Suppressor
1
2007
85
0.290
 Why?
Apoptosis
5
2016
1302
0.280
 Why?
Gene Expression Regulation, Enzymologic
1
2007
205
0.260
 Why?
Receptors, Transforming Growth Factor beta
1
2005
26
0.260
 Why?
Claudin-4
2
2016
7
0.260
 Why?
Ovary
1
2004
105
0.250
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2010
1060
0.250
 Why?
Hysterectomy
2
2014
89
0.240
 Why?
Epithelial Cells
1
2004
255
0.220
 Why?
Reverse Transcriptase Polymerase Chain Reaction
2
2017
674
0.220
 Why?
Aged
11
2021
10054
0.210
 Why?
Neoplasm Staging
4
2021
805
0.210
 Why?
Middle Aged
12
2021
13076
0.210
 Why?
Gene Expression Profiling
3
2019
1141
0.200
 Why?
Cisplatin
2
2015
351
0.190
 Why?
Cell Movement
3
2016
271
0.190
 Why?
Immunohistochemistry
6
2017
1090
0.190
 Why?
Standard of Care
1
2020
16
0.190
 Why?
Resource Allocation
1
2020
19
0.190
 Why?
Disclosure
2
2016
39
0.190
 Why?
Loss of Heterozygosity
2
2013
97
0.180
 Why?
Early Detection of Cancer
1
2021
164
0.180
 Why?
Lymphatic Metastasis
2
2010
256
0.180
 Why?
Leiomyoma
1
2019
29
0.180
 Why?
Leiomyosarcoma
1
2019
25
0.180
 Why?
Neoplasm Invasiveness
3
2015
294
0.170
 Why?
Xenograft Model Antitumor Assays
4
2012
219
0.170
 Why?
Informed Consent
3
2004
92
0.170
 Why?
RNA-Binding Proteins
2
2019
136
0.170
 Why?
Death
1
2018
22
0.160
 Why?
Living Donors
1
2018
25
0.160
 Why?
Palliative Care
1
2020
188
0.160
 Why?
Neoplasms, Glandular and Epithelial
2
2015
48
0.160
 Why?
Critical Care
1
2020
234
0.160
 Why?
Carcinosarcoma
1
2017
18
0.160
 Why?
Microfilament Proteins
1
2017
47
0.160
 Why?
Sequence Analysis, RNA
1
2017
107
0.150
 Why?
Mice, Nude
3
2012
284
0.140
 Why?
Industry
1
2016
19
0.140
 Why?
Adult
7
2021
14189
0.140
 Why?
United States
4
2016
5204
0.140
 Why?
Keratin-5
1
2015
2
0.140
 Why?
Receptors, Androgen
1
2015
49
0.130
 Why?
Carrier Proteins
1
2017
360
0.130
 Why?
Cell Count
1
2015
181
0.130
 Why?
Neoplasm Seeding
1
2014
5
0.130
 Why?
Cell Proliferation
4
2015
1097
0.130
 Why?
Prognosis
4
2017
2126
0.130
 Why?
Genetic Privacy
2
2004
3
0.130
 Why?
Alanine
1
2014
44
0.120
 Why?
Triazines
1
2014
30
0.120
 Why?
Endometrium
1
2014
43
0.120
 Why?
Genes, BRCA2
1
2013
18
0.120
 Why?
Genes, BRCA1
1
2013
24
0.120
 Why?
Insurance, Health, Reimbursement
1
2013
24
0.110
 Why?
Neoplasms, Cystic, Mucinous, and Serous
1
2012
8
0.110
 Why?
Health Care Costs
2
2013
176
0.110
 Why?
DNA Methylation
3
2023
575
0.110
 Why?
Carcinoma, Lobular
1
2012
32
0.110
 Why?
Risk Reduction Behavior
1
2013
69
0.110
 Why?
Mice
6
2016
6428
0.110
 Why?
Paclitaxel
1
2012
103
0.110
 Why?
Coercion
1
2011
6
0.110
 Why?
Judicial Role
1
2011
4
0.110
 Why?
DNA-Binding Proteins
2
2013
462
0.110
 Why?
Medicare Payment Advisory Commission
1
2011
1
0.100
 Why?
Lymph Nodes
1
2014
284
0.100
 Why?
Antibodies, Neoplasm
1
2012
35
0.100
 Why?
Personal Autonomy
1
2011
25
0.100
 Why?
Prejudice
1
2011
43
0.100
 Why?
Women
1
2011
35
0.100
 Why?
Homeodomain Proteins
1
2012
82
0.100
 Why?
Politics
1
2011
28
0.100
 Why?
M Phase Cell Cycle Checkpoints
1
2011
4
0.100
 Why?
Quality of Health Care
1
2013
218
0.100
 Why?
Violence
1
2011
81
0.100
 Why?
Taxoids
1
2011
45
0.100
 Why?
Selective Estrogen Receptor Modulators
1
2010
25
0.100
 Why?
Immunoenzyme Techniques
1
2010
166
0.090
 Why?
Obstetrics
1
2011
89
0.090
 Why?
Organ Specificity
1
2010
126
0.090
 Why?
RNA, Messenger
2
2012
1203
0.090
 Why?
Cesarean Section
1
2011
179
0.090
 Why?
Neoplasm Recurrence, Local
1
2014
645
0.090
 Why?
Models, Statistical
1
2011
258
0.090
 Why?
Alcohol Drinking
1
2011
259
0.090
 Why?
Societies, Medical
1
2010
197
0.090
 Why?
Transfection
2
2012
399
0.080
 Why?
Blotting, Western
1
2010
684
0.080
 Why?
Oligonucleotide Array Sequence Analysis
1
2010
474
0.080
 Why?
Phosphorylation
2
2008
613
0.080
 Why?
Animals
6
2016
14402
0.080
 Why?
Alleles
2
2006
277
0.080
 Why?
Aged, 80 and over
4
2021
3430
0.080
 Why?
Aging
1
2013
782
0.080
 Why?
Chimera
1
2007
13
0.070
 Why?
Case-Control Studies
2
2014
1229
0.070
 Why?
CpG Islands
1
2007
104
0.070
 Why?
Antineoplastic Agents
1
2015
1300
0.070
 Why?
Genomic Imprinting
1
2006
11
0.070
 Why?
Insulin-Like Growth Factor II
1
2006
19
0.070
 Why?
MAP Kinase Signaling System
1
2007
133
0.070
 Why?
RNA, Untranslated
1
2006
17
0.070
 Why?
Health Services Accessibility
1
2010
427
0.070
 Why?
Repetitive Sequences, Amino Acid
1
2005
2
0.070
 Why?
Base Sequence
1
2007
719
0.070
 Why?
North Carolina
1
2005
52
0.070
 Why?
Molecular Sequence Data
1
2007
980
0.060
 Why?
Telomerase
1
2004
30
0.060
 Why?
Databases, Nucleic Acid
1
2004
19
0.060
 Why?
Models, Biological
2
2008
825
0.060
 Why?
Carcinoma
1
2006
154
0.060
 Why?
Tumor Burden
2
2016
141
0.060
 Why?
RNA Interference
2
2016
195
0.060
 Why?
Polymorphism, Genetic
1
2005
193
0.060
 Why?
RNA, Small Interfering
2
2016
253
0.060
 Why?
Promoter Regions, Genetic
1
2007
520
0.060
 Why?
Cell Survival
2
2016
657
0.060
 Why?
Family Health
1
2004
85
0.060
 Why?
Genetic Counseling
1
2004
43
0.060
 Why?
Epigenesis, Genetic
1
2006
399
0.050
 Why?
Genomics
1
2004
313
0.050
 Why?
Ethical Review
1
2002
1
0.050
 Why?
Researcher-Subject Relations
1
2002
2
0.050
 Why?
Contract Services
1
2002
15
0.050
 Why?
Financial Support
1
2002
3
0.050
 Why?
Biotechnology
1
2002
14
0.050
 Why?
Health Care Sector
1
2002
17
0.050
 Why?
Mice, SCID
2
2012
196
0.050
 Why?
Drug Industry
1
2002
40
0.050
 Why?
Genetic Predisposition to Disease
1
2005
571
0.050
 Why?
Research Support as Topic
1
2002
51
0.050
 Why?
Cell Line
1
2004
1152
0.050
 Why?
Research Subjects
1
2002
57
0.050
 Why?
Neoplasm Grading
1
2021
131
0.050
 Why?
Patient Selection
1
2002
284
0.050
 Why?
Cooperative Behavior
1
2002
253
0.040
 Why?
Intramolecular Oxidoreductases
1
2019
17
0.040
 Why?
Cytoskeletal Proteins
1
2019
58
0.040
 Why?
Microtubule-Associated Proteins
1
2019
78
0.040
 Why?
Risk Assessment
1
2023
1361
0.040
 Why?
Biomedical Research
1
2002
235
0.040
 Why?
Cell Cycle Proteins
1
2019
198
0.040
 Why?
Sensitivity and Specificity
1
2019
922
0.040
 Why?
Cohort Studies
1
2021
1547
0.040
 Why?
Caspase 3
1
2016
135
0.040
 Why?
Tissue Array Analysis
1
2015
50
0.030
 Why?
Retrospective Studies
2
2021
6462
0.030
 Why?
Epithelial-Mesenchymal Transition
1
2015
53
0.030
 Why?
Diagnosis, Differential
1
2019
1143
0.030
 Why?
Exosomes
1
2015
45
0.030
 Why?
HEK293 Cells
1
2015
245
0.030
 Why?
Receptor, Fibroblast Growth Factor, Type 2
1
2014
11
0.030
 Why?
Peritoneal Cavity
1
2014
6
0.030
 Why?
Prospective Studies
1
2021
2604
0.030
 Why?
Cell Transformation, Neoplastic
1
2015
200
0.030
 Why?
Risk Factors
2
2014
3934
0.030
 Why?
Drug Resistance, Neoplasm
1
2015
309
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2014
233
0.030
 Why?
Disease-Free Survival
1
2014
488
0.030
 Why?
Homologous Recombination
1
2013
43
0.030
 Why?
MCF-7 Cells
1
2013
79
0.030
 Why?
Germ-Line Mutation
1
2013
68
0.030
 Why?
Amino Acid Substitution
1
2013
105
0.030
 Why?
Karyotyping
1
2012
92
0.030
 Why?
Anoikis
1
2012
9
0.030
 Why?
Databases, Factual
1
2016
683
0.030
 Why?
Extracellular Matrix Proteins
1
2013
75
0.030
 Why?
Transduction, Genetic
1
2012
50
0.030
 Why?
Tubulin
1
2012
28
0.030
 Why?
Mice, Inbred NOD
1
2012
99
0.030
 Why?
DNA Fingerprinting
1
2012
38
0.030
 Why?
Tamoxifen
1
2012
61
0.030
 Why?
Cell Adhesion
1
2012
171
0.030
 Why?
Antibody Specificity
1
2012
48
0.030
 Why?
Signal Transduction
2
2011
1751
0.030
 Why?
Perioperative Period
1
2011
25
0.030
 Why?
Tumor Suppressor Protein p53
1
2013
251
0.030
 Why?
Estradiol
1
2012
219
0.020
 Why?
Amino Acid Sequence
1
2013
766
0.020
 Why?
Cell Cycle Checkpoints
1
2011
35
0.020
 Why?
Microtubules
1
2011
57
0.020
 Why?
Disease Models, Animal
1
2016
1651
0.020
 Why?
Mitosis
1
2011
106
0.020
 Why?
Regression Analysis
1
2011
444
0.020
 Why?
Gene Expression
1
2013
664
0.020
 Why?
HeLa Cells
1
2011
291
0.020
 Why?
Disease Progression
1
2012
915
0.020
 Why?
Cells, Cultured
1
2013
1737
0.020
 Why?
Progesterone Congeners
1
2008
5
0.020
 Why?
Severity of Illness Index
1
2011
1083
0.020
 Why?
Progesterone
1
2008
69
0.020
 Why?
Protein Kinases
1
2008
88
0.020
 Why?
Cell Nucleus
1
2008
203
0.020
 Why?
Tumor Cells, Cultured
1
2008
477
0.020
 Why?
Mutation
1
2013
1504
0.020
 Why?
Transcriptional Activation
1
2006
134
0.020
 Why?
DNA, Neoplasm
1
2006
171
0.020
 Why?
Protein Structure, Tertiary
1
2006
289
0.020
 Why?
Binding Sites
1
2006
440
0.020
 Why?
Repressor Proteins
1
2006
165
0.020
 Why?
Pregnancy
1
2011
2637
0.020
 Why?
Truth Disclosure
1
2004
18
0.020
 Why?
Genetic Diseases, Inborn
1
2004
26
0.010
 Why?
Male
1
2011
27335
0.010
 Why?
Spillman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (262) concept(s)
_
Similar People Expand Description
See all (36) people
_